Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
Date:11/10/2008

Keryx to Host Investor Conference Call on Tuesday, November 11, 2008 at

8:30am EST

NEW YORK, Nov. 10 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer, today announced its results for the third quarter ended September 30, 2008.

At September 30, 2008, the Company had cash, cash equivalents, investment securities and interest receivable of $26.5 million, as compared to $64.7 million at December 31, 2007. Approximately $9.2 million of the Company's investments, at September 30, 2008, represent auction rate securities, which are classified as long-term investments.

The net loss for the third quarter ended September 30, 2008 was $6,841,000, or $0.15 per share, compared to a net loss of $19,528,000, or $0.45 per share, for the comparable quarter in 2007, representing a decrease in net loss of $12,687,000. The decrease in net loss was primarily attributable to a $11,699,000 decrease in research and development expenses related to the cessation of the development of Sulonex in March 2008, a $1,860,000 decrease in expenses related to our other clinical compounds, and a $519,000 decrease in non-cash compensation expense related to equity incentive grants, partially offset by a $1,639,000 decrease in interest and other income (expense), net.

Commenting on the quarter, Michael S. Weiss, Keryx's Chairman and Chief Executive Officer, said, "During the third quarter, we continued to make progress in our Zerenex and Perifosine clinical programs, whi
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
3. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
5. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
6. Transition Therapeutics Announces First Quarter Fiscal 2009 Financial Results
7. Bradmer announces 2008 third quarter operational and financial results
8. Hillenbrand, Inc. Announces Fourth-Quarter Earnings Release Date and Conference Call
9. TransTech Services Partners Inc. Announces Election of Dr. Ranga C. Krishna as a Director
10. URAC Announces Finalists for Best Practices in Health Care Consumer Empowerment and Protection Awards
11. Heska Announces Q3 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Philadelphia, PA, June 19, 2013 Recent studies ... coverage of bullying-related suicide among young people, led ... to assemble an expert panel to focus on ... about the complex relationship between youth involvement in ... Bullying among youth is a significant public health ...
(Date:6/18/2013)... New York, New York (PRWEB) June 19, 2013 ... dedicated to protecting the rights of victims injured by ... on behalf of an Arizona woman who alleges that ... The suit was filed on May 30th in the ... Virginia (Civil Action No. 2:13-cv-12677) in the multidistrict litigation ...
(Date:6/18/2013)... 2013 An apple a day might ... was diagnosed with breast cancer, she chose a different ... “I Gave Myself Cancer, I Can Take It Away!: ... Press), Beauregard explains how changing her physical, mental and ... have been made to feel fearful when diagnosed with ...
(Date:6/18/2013)... Looking for a way to break out of ... , IWALKAWAKE is a guide to unlocking one’s true potential ... focuses on harnessing the powerful and abundant spiritual presence that ... nine-step guide to finding one’s true purpose and potential. These ... through to reach their true potential. The awakenings deal with ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Cheap Concert Tickets ... for the tournament which gets underway in July. Soccer ... any CONCACAF ticket order. , The popularity and ... of the globe.    In fact, the hype of the game triggered ... popularity also trickled down the veins of fans from the ...
Breaking Medicine News(10 mins):Health News:Bullying and suicide among youth is a public health problem 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:Cancer Survivor Linda Christina Beauregard Writes New Tell-All Book About Her Alternative Treatment Method 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 3
... HIV infection is on the rise among young men who have ... data from the Health Department. New HIV diagnoses among MSM under ... the agency reported today, from 374 in 2001 to almost 500 ... while declining by 22% among older MSM. The under-30 group now ...
... As part of an,initiative to give back ... its annual scientific meetings, the American Society for ... Wellness Community -,South Bay Cities to raise awareness ... Wellness Community will join forces with ASTRO by,participating ...
... Pa., Sept. 11 The Department of,Public Welfare ... health system whose personal information may have been ... DPW office building in Harrisburg., The burglary ... of the information on the stolen computers has ...
... 11 Crystal Research Associates, LLC,announced today that ... Tapestry Pharmaceuticals, Inc. (Nasdaq: TPPH ). The ... . Tapestry Pharmaceuticals, Inc. ("Tapestry" or "the ... that may be,effective in treating a broad spectrum ...
... Transcept,Pharmaceuticals, Inc., a specialty pharmaceutical company deriving,significant new ... Glenn A. Oclassen, President and Chief Executive Officer ... Life Sciences Conference at the Grand,Hyatt, New York, ... p.m. ET. About Transcept Pharmaceuticals Transcept ...
... CryoCor, Inc. (Nasdaq:,CRYO), a medical device company focused ... it has been invited to participate in a,Food ... held on September,20, 2007 from 8:00 am to ... committee will discuss and make recommendations regarding clinical,trial ...
Cached Medicine News:Health News:New HIV diagnoses rising in New York City among young men who have sex with men 2Health News:New HIV diagnoses rising in New York City among young men who have sex with men 3Health News:New HIV diagnoses rising in New York City among young men who have sex with men 4Health News:ASTRO, Wellness Community South Bay Cities Join to Promote Cancer Survivorship 2Health News:PA Department of Public Welfare Begins Outreach to Medical Assistance Consumers Following Burglary at State Office Building 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc. 3Health News:CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation 2
(Date:6/18/2013)... , June 18, 2013  Cataracts are the ... the American Association of Ophthalmology, aging is the leading ... of the eye,s natural lens. 22 million Americans age ... Baby Boomers continue to age, that number will increase ... world of iPhones, iPads, smart-phones and computers, the demographic ...
(Date:6/18/2013)... 2013 MPR is excited to unveil a ... It,s all part of an ongoing effort to freshen the ... for over 28 years. (Photo: http://photos.prnewswire.com/prnh/20130618/NY33937 ... MPR has expanded upon its foundation as a ... include an increasing array of clinical and practice management tools ...
(Date:6/18/2013)... FRANKLIN LAKES, N.J. and NEW YORK ... (Becton, Dickinson and Company) (NYSE: BDX ) are ... insulin infusion and glucose sensing technologies through a new collaboration ... existing JDRF-BD collaborations focused on type 1 diabetes (T1D). ... via an insulin pump – requiring a catheter to be ...
Breaking Medicine Technology:New Vision Hope For Millions Undergoing Cataract Surgery 2New Vision Hope For Millions Undergoing Cataract Surgery 3MPR Sports a Bold New Look 2JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3
... Sept. 16 Boston Scientific Corporation (NYSE: ... Drug Administration (FDA) has approved an expanded indication for ... CRT-D.  The exclusive expanded indication is effective immediately and ... the FDA for patients in all New York Heart ...
... Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) ... and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory ... do not adequately demonstrate that the potential benefits of ... a population of overweight and obese individuals to allow ...
Cached Medicine Technology:Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds 2Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds 3Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds 4Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting 2Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting 3Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting 4
... Seat height: Bench high, 26-31". Ergonomic ... "Soft Touch" pnuematic control for easy ... Static-control casters allow easy mobility. Fixed ... Decay (from 5000 Volts to technical ...
Attachments: Clip bar for tubes 10 to 19 mm in diameter Overall Dimension Height IC: 6 (15.2) Overall Dimension Length IC: 18.5 (46.9) Overall Dimension Width IC: 4 (10.2)...
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
Medicine Products: